Department of Family Medicine, 66978American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.
Department of Obstetrics and Gynecology, 66984American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.
Cancer Control. 2022 Jan-Dec;29:10732748211068634. doi: 10.1177/10732748211068634.
Invasive cervix uteri cancer is the fourth most common malignancy in women globally. This study investigates the incidence and trends of cervix uteri cancer in Lebanon, a country in the Middle East, and compares these rates to regional and global ones.
Data on cervix uteri were obtained from the Lebanese national cancer registry for the currently available years 2005 to 2016. The calculated age-standardized incidence and age-specific rates were expressed as per 100,000 population.
From 2005 to 2016, cervix uteri cancer was the tenth most common cancer among women. Its age-standardized incidence rate fluctuated narrowly between 3.5 and 5.7 per 100,000, with the lowest rate in 2013 and the highest rate in 2012. The age-specific incidence rate had 2 peaks, the highest peak at age group 70-74 years and the second at age group 50-59 years. The annual percent change (+.05%) showed a non-statistically significant trend of increase. The age-standardized incidence rate of cervix uteri cancer in Lebanon was comparable to that of the Western Asia region that has the lowest incidence rate worldwide. The rate was intermediate as compared to other countries in the Middle East and North Africa Region and relatively similar to the ones in Australia, North America, and some Western European countries.
The incidence rates of invasive cervix uteri are low in Lebanon. This could be attributed to the low prevalence of human papilloma virus infection and other sexually transmitted infections among Lebanese women, and the opportunistic screening practices. It is important to adopt a comprehensive approach to decrease the potential burden of cervix uteri, especially with the rising patterns of risky sexual behaviors. This includes improving awareness, enhancing access to preventive services, developing clinical guidelines, and training health care providers on these guidelines.
在全球范围内，浸润性宫颈癌是女性中第四大常见恶性肿瘤。本研究调查了中东国家黎巴嫩宫颈癌的发病率和趋势，并将这些数据与区域和全球数据进行了比较。
从 2005 年至 2016 年，我们从黎巴嫩国家癌症登记处获得了有关宫颈癌的数据。计算得出的年龄标准化发病率和年龄特异性发病率用每 10 万人表示。
从 2005 年至 2016 年，宫颈癌是女性中第十大常见癌症。其年龄标准化发病率在 3.5 至 5.7 之间波动，2013 年最低，2012 年最高。年龄特异性发病率有 2 个高峰，最高峰在 70-74 岁年龄组，第二个高峰在 50-59 岁年龄组。年变化百分比（+.05%）呈非显著上升趋势。黎巴嫩宫颈癌的年龄标准化发病率与全球发病率最低的西亚地区相当。与中东和北非地区的其他国家相比，这一比率处于中等水平，与澳大利亚、北美和一些西欧国家的比率也较为相似。
黎巴嫩浸润性宫颈癌的发病率较低。这可能归因于黎巴嫩女性中 HPV 感染和其他性传播感染的低流行率，以及机会性筛查做法。重要的是，要采取综合方法来降低宫颈癌的潜在负担，尤其是在性行为风险上升的情况下。这包括提高认识、加强获得预防服务的机会、制定临床指南以及就这些指南对卫生保健提供者进行培训。
